P1369: HDAC INHIBITION INVOLVES CD26 EXPRESSION ON MULTIPLE MYELOMA CELLS VIA THE C-MYC/SP1-MEDIATED PROMOTER ACTIVATION AND OVERCOMES THERAPEUTIC RESISTANCE BY HUMANIZED ANTIBODY

• Hiroko Nishida,
• Reiko Suzuki,
• Kiyora Nakajima,
• Chikao Morimoto,
• Michiie Sakamoto

Affiliations

Hiroko Nishida

1 Keio University, School of Medicine, Pathology, Tokyo, Japan

Reiko Suzuki

2 Keio University, School of Medicine, Collaborative Research Resources, Tokyo, Jamaica

Kiyora Nakajima

1 Keio University, School of Medicine, Pathology, Tokyo, Japan

Chikao Morimoto

3 Juntendo University, Graduate School of Medicine, Therapy Development and Innovation for Immune Disorders and Cancers, Tokyo, Japan

Michiie Sakamoto

1 Keio University, School of Medicine, Pathology, Tokyo, Japan